NFKB1 and rheumatoid arthritis: Since a transcription factor NF-κB serves as a pivotal mediator of inflammatory responses [11], the suppression of NF-κB activity by PAL is deemed an effective therapeutic strategy for various inflammatory diseases, such as neurodegenerative disorders and rheumatoid arthritis.